Los Angeles Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-118,664
Closed -$894K 2401
2025
Q4
$894K Sell
118,664
-20,549
-15% -$106K ﹤0.01% 671
2025
Q3
$969K Buy
+139,213
New +$982K ﹤0.01% 712
2024
Q1
Sell
-28,626
Closed -$452K 1128
2023
Q4
$452K Buy
+28,626
New +$296K ﹤0.01% 902
2023
Q3
Sell
-32,900
Closed -$260K 1118
2023
Q2
$260K Sell
32,900
-26,471
-45% -$184K ﹤0.01% 1050
2023
Q1
$442K Sell
59,371
-42,784
-42% -$425K ﹤0.01% 891
2022
Q4
$1.2M Sell
102,155
-1,400
-1% -$16K 0.01% 649
2022
Q3
$955K Buy
+103,555
New +$1.25M 0.01% 714

Other funds holding ASPN

Los Angeles Capital Management's ASPN Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 118,664 shares — an estimated $894K sold.

Los Angeles Capital Management first reported a position in ASPN in Q3 2022 and held it in 7 quarters. The position peaked at $1.2M in Q4 2022. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 118,664 Aspen Aerogels shares in Q1 2026, an estimated $894K.
  • Los Angeles Capital Management first reported a position in Aspen Aerogels in Q3 2022 and held it in 7 quarters.
  • Los Angeles Capital Management's Aspen Aerogels position peaked at $1.2M in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.